Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CERUS CORPORATION
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2020-09-24 to 2025-09-28
Current total value of award: $11106465
Description: BAA PROPOSAL EETWP33 DEVELOPMENT OF AN OPTIMIZED PATHOGEN INACTIVATION PROCESS FOR WHOLE BLOOD